Joint Replacement Market Size, Share, Growth, and Industry Analysis, By Type (Hip Replacement,Knee Replacement,Extremities Replacement), By Application (Below 45,45-64,Above 65), Regional Insights and Forecast to 2035

Joint Replacement Market Overview

The global Joint Replacement Market size is projected to grow from USD 13295.63 million in 2026 to USD 13540.27 million in 2027, reaching USD 15669.81 million by 2035, expanding at a CAGR of 1.84% during the forecast period.

The global Joint Replacement Market involves implants, surgical instruments and associated devices for hip, knee, shoulder, extremities and revision surgeries. In 2022, the estimated global joint replacement market size was about USD 20,893.3 million (i.e. 20,893.3 million) per one analysis. The knee segment alone accounted for USD 9,892.0 million in 2022 within that total. In 2023, the global joint replacement devices market was valued at about USD 22,500 million, rising toward projected figures. The Joint Replacement Market Report and Joint Replacement Market Insights show that about 3.6 million knee replacements were performed globally in 2023, with roughly 40 % of those procedures occurring in the United States.

In the United States, about 790,000 total knee replacement surgeries occur annually and about 544,000 hip replacement procedures per year by some estimates. The Joint Replacement Industry Report indicates that between 2022 and 2023 U.S. hip and knee implant procedures increased by 4.6 % to a total of 2.15 million such procedures in one year alone. The American Joint Replacement Registry (AJRR) database now holds over 4 million recorded hip and knee arthroplasty procedures. The U.S. share of global joint replacement procedures is often cited around 30 %–40 % in many analyses, underpinning its dominance in the Joint Replacement Market Analysis context.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 45 % of global joint replacement growth attributed to increasing obesity and osteoarthritis incidence
• Major Market Restraint: 25 % of postponed surgeries due to lack of insurance coverage
• Emerging Trends: 30 % annual increase in use of robotic-assisted procedures
• Regional Leadership: North America holds around 62.9 % share in many market reports
• Competitive Landscape: Top 3 firms account for nearly 50 % share of global implant shipments
• Market Segmentation: Knee segment accounts for ~46 % share; hips ~37 %; extremities & others ~17 %
• Recent Development: 40 % of new implants now use 3D-printed porous surfaces

Joint Replacement Market Latest Trends

The Joint Replacement Market Trends reflect rapid adoption of robotic-assisted surgery, patient-specific instrumentation, smart implants with sensors, and additive manufacturing. In 2023, the share of robotic systems in total joint procedures rose by 12 %, moving from 8 % to 20 % penetration in leading markets. Use of 3D-printed porous titanium scaffolds increased by 40 % year-on-year in new hip and knee implants. The Joint Replacement Market Analysis suggests that partial and revision joint replacements now constitute about 22 % of all procedures, up from 15 % five years ago. Uptake of outpatient joint replacement procedures grew by 25 % in the U.S. between 2021 and 2023, reflecting a shift in site of care. The Joint Replacement Market Forecast indicates rising demand in younger age groups (45–64), where procedure counts increased by 211 % for hip and 240 % for knee replacements from 2000 to 2017. These trends in Joint Replacement Market Outlook highlight a move toward more personalized, efficient, and minimally invasive solutions.

Joint Replacement Market Dynamics

DRIVER

"Rising incidence of osteoarthritis and obesity"

The incidence of osteoarthritis globally affects more than 500 million people currently and is projected to approach 1 billion by 2050. The obesity epidemic contributes to joint stress; each additional pound adds ~4 lb stress per knee joint, accelerating wear. From 2000 to 2019, primary total hip arthroplasty (THA) volume rose by 177 %, and total knee arthroplasty (TKA) volume rose by 156 %. Medicare database projections anticipate THA and TKA volumes will further increase by ~28.8 % and 24.3 %, respectively, per 5-year interval beyond 2020. In many countries, aging populations (e.g. >65 years growing by 3 % annually) drive higher demand. These data underpin Joint Replacement Market Growth in the Joint Replacement Industry Report.

RESTRAINT

"Reimbursement constraints and high out-of-pocket costs"

In many systems, 25 % or more of elective joint surgeries are delayed or cancelled because patients lack sufficient insurance or face high co-payments. Some public payers restrict coverage for younger patients under age 55 for primary implants. Additionally, a backlog in hospital capacity causes 10 %–15 % of eligible surgeries to be deferred annually. Regulatory and quality approval cycles delay new implant introduction by 2–3 years in many jurisdictions. Supply chain disruptions in implant titanium, cobalt, and polyethylene drive cost overruns of 8 %–12 %. Such constraints are features in Joint Replacement Market Restraint sections of Joint Replacement Market Report.

OPPORTUNITY

"Expansion in emerging markets and medical tourism"

Emerging markets in Asia-Pacific, Latin America, and Middle East present growth opportunity: Asia-Pacific share increased from 12 % to ~18 % of total joint procedure volume in the past decade. In India and China, annual hip fracture counts are projected to reach 2.6 million by 2050. Many private hospitals in Southeast Asia report 20 %–30 % revenue growth in joint replacement services annually. Medical tourism flows from countries lacking advanced orthopaedic infrastructure inject foreign patient volumes e.g. Thailand saw 15,000 orthopedic tourists in 2023. There is also opportunity in smart implants with sensors (expected adoption uptake of 30 % in next 5 years) and revision implants where demand is increasing: U.S. data projects 72,000 revision hip and 120,000 revision knee surgeries annually by 2030. The Joint Replacement Market Opportunities section in Joint Replacement Market Research Report emphasizes these.

CHALLENGE

"Implant longevity, revision burden and surgeon capacity"

A key challenge is long-term implant wear and revision risk: many hip implants last 15–20 years, but revision surgeries account for ~10 % of cases in leading markets. Surgeons report burnout, and workforce constraints limit annual throughput: U.S. orthopedic societies estimate doubling of joint arthroplasty caseload is required by 2050 to meet demand. In 2019, ~1.25 million total joint arthroplasty surgeries (hip + knee) were performed in the U.S., but the orthopaedic workforce capacity has not scaled accordingly. In complex revisions, bone loss and alignment challenges increase complication rates 2–3× above primaries. In some countries, sterilization or regulatory obstacles delay adoption of new materials by 18–24 months. These challenges are core to Joint Replacement Industry Analysis and Joint Replacement Market Research Report narratives.

Joint Replacement Market Segmentation

The Joint Replacement Market Segmentation is commonly presented by Type and Application to structure Joint Replacement Market Share and Joint Replacement Market Size assessments.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Hip Replacement: Hip replacements represent ~37 % of global joint replacement procedure value in many reports. In 2019, U.S. primary THA count was about 262,369 per year; that figure has grown subsequently. The U.S. currently performs ~544,000 hip replacements annually (depending on source). Young patient cases (under age 55) account for 28 % of total hip replacements in some data sets. The use of ceramic-on-ceramic, dual mobility, and modular neck implants has risen by 20 % year-on-year in high volume centers. Hip revision rates over 10 years are approximately 5 %–7 % depending on implant type.

The Hip Replacement segment of the Joint Replacement market in 2025 is valued at USD 4820.76 million, accounting for 36.9% share, projected to reach USD 5680.94 million by 2034 at a CAGR of 1.83%.

Top 5 Major Dominant Countries in the Hip Replacement Segment

• United States: Market size USD 1653.51 million in 2025 with 34.3% share, projected to reach USD 1912.84 million by 2034 at a CAGR of 1.64%, driven by high procedure volumes and innovation.
• Germany: Market size USD 694.45 million in 2025 with 14.4% share, projected to reach USD 822.67 million by 2034 at a CAGR of 1.90%, supported by registry systems and advanced implant adoption.
• Japan: Market size USD 503.18 million in 2025 with 10.4% share, projected to reach USD 607.96 million by 2034 at a CAGR of 2.14%, driven by aging demographics and procedure standardization.
• China: Market size USD 417.58 million in 2025 with 8.7% share, projected to reach USD 524.92 million by 2034 at a CAGR of 2.47%, supported by rapid hospital capacity expansion.
• France: Market size USD 346.04 million in 2025 with 7.2% share, projected to reach USD 399.13 million by 2034 at a CAGR of 1.60%, with strong reimbursement and demand growth.

Knee Replacement: Knee replacement is often the largest segment it accounted for ~46 % share of global joint replacement market revenue in 2020. In U.S. data, about 480,958 primary TKA procedures were performed in 2019. Globally, ~3.6 million knee replacements were done in 2023; the U.S. performs ~40 % of them. Partial knee procedures represent ~10 % of total knee surgeries. Mobile-bearing implants have grown in share by 8 % over 5 years. Revision knee surgeries are projected at 120,000 cases annually in some forecasts.

The Knee Replacement segment of the Joint Replacement market in 2025 is valued at USD 5783.88 million, representing 44.3% share, projected to reach USD 6749.22 million by 2034 at a CAGR of 1.74%, supported by rising osteoarthritis cases.

Top 5 Major Dominant Countries in the Knee Replacement Segment

• United States: Market size USD 2081.95 million in 2025 with 36.0% share, projected to reach USD 2360.16 million by 2034 at a CAGR of 1.46%, reflecting large surgical volumes.
• United Kingdom: Market size USD 623.18 million in 2025 with 10.8% share, projected to reach USD 699.65 million by 2034 at a CAGR of 1.31%, supported by NHS-funded procedures.
• India: Market size USD 462.71 million in 2025 with 8.0% share, projected to reach USD 603.36 million by 2034 at a CAGR of 2.99%, fueled by expanding middle-class healthcare demand.
• Germany: Market size USD 492.44 million in 2025 with 8.5% share, projected to reach USD 552.92 million by 2034 at a CAGR of 1.30%, aided by high per capita implant rates.
• China: Market size USD 405.96 million in 2025 with 7.0% share, projected to reach USD 520.34 million by 2034 at a CAGR of 2.87%, supported by increased joint centers.

Extremities Replacement: Extremities replacements (shoulder, elbow, wrist, ankle, hand) typically account for ~17 % of the market. The global small joint replacement market (wrist, hand, elbow ankle) was valued at ~USD 5.2 billion in 2023. Shoulder replacements segment is valued at ~USD 400.8 million in 2023 alone. In mature markets, shoulder replacements growth has been ~4 % per year, with reverse shoulder designs now about 60 % of shoulder implant usage.

The Extremities Replacement segment of the Joint Replacement market in 2025 is valued at USD 2450.77 million, comprising 18.8% share, projected to reach USD 2956.53 million by 2034 at a CAGR of 2.11%, driven by shoulder and ankle implant demand.

Top 5 Major Dominant Countries in the Extremities Replacement Segment

• United States: Market size USD 734.00 million in 2025 with 29.9% share, projected to reach USD 876.20 million by 2034 at a CAGR of 1.99%, supported by strong adoption of reverse shoulder systems.
• France: Market size USD 335.00 million in 2025 with 13.7% share, projected to reach USD 405.61 million by 2034 at a CAGR of 2.17%, reflecting growth in shoulder and elbow procedures.
• Japan: Market size USD 279.83 million in 2025 with 11.4% share, projected to reach USD 343.10 million by 2034 at a CAGR of 2.30%, driven by aging society and advanced techniques.
• Germany: Market size USD 267.58 million in 2025 with 10.9% share, projected to reach USD 311.41 million by 2034 at a CAGR of 1.70%, reflecting robust registry tracking of extremity implants.
• China: Market size USD 240.36 million in 2025 with 9.8% share, projected to reach USD 303.02 million by 2034 at a CAGR of 2.62%, supported by broader availability of extremity implants.

BY APPLICATION

Below 45: Patients younger than 45 years account for about 5 %–8 % of joint replacement cases in developed markets. However, demand in this cohort has grown: for hip, under-55 cases represent 28 % of annual volume; for knee, increases in obesity and injury drive earlier interventions. The revision risk in this group is higher: 10-year revision rate may compare at 7 %–10 % versus 3 %–5 % in older cohorts. Implant designs targeting younger patients (e.g. modular, bone preserving) now represent ~15 % of new product launches.

The Below 45 segment of the Joint Replacement market in 2025 is valued at USD 980.00 million, holding 7.5% share, projected to reach USD 1136.87 million by 2034 at a CAGR of 1.67%.

Top 5 Major Dominant Countries in the Below 45 Application

• United States: Market size USD 311.84 million in 2025 with 31.8% share, projected to reach USD 358.12 million by 2034 at a CAGR of 1.57%.
• India: Market size USD 201.69 million in 2025 with 20.6% share, projected to reach USD 253.19 million by 2034 at a CAGR of 2.49%.
• China: Market size USD 157.68 million in 2025 with 16.1% share, projected to reach USD 200.64 million by 2034 at a CAGR of 2.73%.
• Germany: Market size USD 139.15 million in 2025 with 14.2% share, projected to reach USD 158.49 million by 2034 at a CAGR of 1.47%.
• Brazil: Market size USD 117.64 million in 2025 with 12.0% share, projected to reach USD 136.43 million by 2034 at a CAGR of 1.61%.

45-64L: This middle age group constitutes approximately 40 %–50 % of all joint replacement procedures in many markets. In the U.S., the largest growth in utilization over past two decades occurred in the 45–64 bracket: hip +211 %, knee +240 % from 2000 to 2017 in that age slice. These patients often demand high activity, driving adoption of advanced bearings, navigation, and robotic assistance. Revision rates in this cohort after 10 years may be 5 %–8 %. Many manufacturers now tailor implant designs (e.g. kinematic knee, dual mobility hip) to meet functional demands of this demographic.

The 45–64 segment of the Joint Replacement market in 2025 is valued at USD 5120.00 million, comprising 39.2% share, projected to reach USD 6000.37 million by 2034 at a CAGR of 1.81%.

Top 5 Major Dominant Countries in the 45–64 Application

• United States: Market size USD 1736.73 million in 2025 with 33.9% share, projected to reach USD 1998.28 million by 2034 at a CAGR of 1.60%.
• Germany: Market size USD 643.64 million in 2025 with 12.6% share, projected to reach USD 721.80 million by 2034 at a CAGR of 1.28%.
• Japan: Market size USD 517.68 million in 2025 with 10.1% share, projected to reach USD 622.48 million by 2034 at a CAGR of 2.08%.
• China: Market size USD 484.69 million in 2025 with 9.5% share, projected to reach USD 602.61 million by 2034 at a CAGR of 2.42%.
• France: Market size USD 395.38 million in 2025 with 7.7% share, projected to reach USD 452.39 million by 2034 at a CAGR of 1.56%.

Above 65: Patients older than 65 make up ~42 %–50 % of total joint procedures in many developed economies. The average age for TKA is ~67.2 years; for THA ~65.7 years in U.S. registry data. Revision risk in older patients is lower due to lower activity; 10-year revision rates often ~3 %–5 %. Many older patients present with co-morbidities; length of hospital stay averages 3–4 days in U.S. for knee, 2–3 days for hip. In this group, cemented fixation remains ~49 % of hip/knee procedures in older cohorts in many markets, given proven survivorship.

The Above 65 segment of the Joint Replacement market in 2025 is valued at USD 6955.41 million, representing 53.3% share, projected to reach USD 8249.45 million by 2034 at a CAGR of 1.84%.

Top 5 Major Dominant Countries in the Above 65 Application

• United States: Market size USD 2448.42 million in 2025 with 35.2% share, projected to reach USD 2855.52 million by 2034 at a CAGR of 1.72%.
• Japan: Market size USD 835.62 million in 2025 with 12.0% share, projected to reach USD 1025.55 million by 2034 at a CAGR of 2.27%.
• Germany: Market size USD 830.15 million in 2025 with 11.9% share, projected to reach USD 948.02 million by 2034 at a CAGR of 1.49%.
• China: Market size USD 699.23 million in 2025 with 10.1% share, projected to reach USD 856.11 million by 2034 at a CAGR of 2.26%.
• France: Market size USD 564.91 million in 2025 with 8.1% share, projected to reach USD 636.82 million by 2034 at a CAGR of 1.37%.

Joint Replacement Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America, particularly the U.S., dominates many Joint Replacement Industry Reports, often accounting for more than 62.9 % of global joint replacement market revenue (as per a 2020 benchmark). In 2019, the U.S. performed ~1.5 million hip and knee arthroplasty surgeries that were recorded in the American Joint Replacement Registry. In 2023, the AJRR database surpassed 4 million recorded hip and knee procedures. U.S. hip and knee implant procedures between 2022 and 2023 rose by 4.6 % to 2.15 million annual procedures. In U.S. procedure volumes, ~790,000 knee and ~544,000 hip replacements occur yearly.

The North America Joint Replacement market in 2025 is valued at USD 5726.38 million, capturing 43.9% share, projected to reach USD 6572.34 million by 2034 at a CAGR of 1.56%, led by U.S. and Canada.

North America - Major Dominant Countries in the Joint Replacement Market

• United States: Market size USD 3730.37 million in 2025 with 65.1% share, projected to reach USD 4245.92 million by 2034 at a CAGR of 1.45%.
• Canada: Market size USD 714.20 million in 2025 with 12.5% share, projected to reach USD 857.60 million by 2034 at a CAGR of 1.91%.
• Mexico: Market size USD 553.00 million in 2025 with 9.6% share, projected to reach USD 664.45 million by 2034 at a CAGR of 2.00%.
• Cuba: Market size USD 365.90 million in 2025 with 6.4% share, projected to reach USD 421.87 million by 2034 at a CAGR of 1.60%.
• Puerto Rico: Market size USD 362.91 million in 2025 with 6.3% share, projected to reach USD 382.50 million by 2034 at a CAGR of 0.59%.

Europe

In Europe, major markets include Germany, UK, France, Italy, and Spain. In Germany, for example, ~301 hip and ~201 knee replacements per 100,000 population were reported by OECD data. European National Joint Registry data show ~99,043 primary hip and ~98,469 primary knee replacements in 2022 in the UK alone. The European share of global joint replacement market is often ~25 %–30 %. In Europe, public healthcare systems and national bidding reduce implant costs; 30 % discounting is common in tenders. Robotic adoption in Europe trails U.S. by ~5–7 years, but growth in robot usage is ~15 % annually in leading markets (Germany, France, Italy). For hip implants, metal-on-polyethylene designs remain ~35 % share; modular neck and dual-mobility designs are rising at ~10 % share growth annually.

The Europe Joint Replacement market in 2025 is valued at USD 4019.14 million, representing 30.8% share, projected to reach USD 4720.78 million by 2034 at a CAGR of 1.80%, with Germany, UK, and France leading.

Europe - Major Dominant Countries in the Joint Replacement Market

• Germany: Market size USD 1255.33 million in 2025 with 31.2% share, projected to reach USD 1431.00 million by 2034 at a CAGR of 1.45%.
• United Kingdom: Market size USD 835.63 million in 2025 with 20.8% share, projected to reach USD 986.44 million by 2034 at a CAGR of 1.88%.
• France: Market size USD 720.32 million in 2025 with 17.9% share, projected to reach USD 846.25 million by 2034 at a CAGR of 1.81%.
• Italy: Market size USD 621.32 million in 2025 with 15.5% share, projected to reach USD 730.65 million by 2034 at a CAGR of 1.83%.
• Spain: Market size USD 586.54 million in 2025 with 14.6% share, projected to reach USD 726.44 million by 2034 at a CAGR of 2.42%.

Asia-Pacific

Asia-Pacific is often cited in Joint Replacement Market Forecasts as the fastest growing region. Its share of global procedures has increased from ~12 % to ~18 % in the last decade. China, India, Japan are leaders. In 2019 Asia had ~1.2 million hip fractures; projected to reach ~2.6 million by 2050. In China, private hospitals report 15 %–20 % annual growth in orthopaedic services. In India, joint replacement surgeries rose ~22 % annually in private hospitals from 2020 to 2023. Robotic systems installed in Asia grew from ~5 units in 2018 to ~45 units in 2023, representing ~9× growth. In Japan, the number of joint replacement procedures per 100,000 inhabitants is rising at ~4 % per year. Out-of-pocket share remains higher (often > 30 %), but growing insurance penetration and government subsidy programs drive uptake.

The Asia Joint Replacement market in 2025 is valued at USD 2261.14 million, making up 17.3% share, projected to reach USD 2801.60 million by 2034 at a CAGR of 2.39%, led by China, Japan, and India.

Asia - Major Dominant Countries in the Joint Replacement Market

• China: Market size USD 945.66 million in 2025 with 41.8% share, projected to reach USD 1189.47 million by 2034 at a CAGR of 2.49%.
• Japan: Market size USD 816.68 million in 2025 with 36.1% share, projected to reach USD 1006.25 million by 2034 at a CAGR of 2.38%.
• India: Market size USD 328.44 million in 2025 with 14.5% share, projected to reach USD 420.28 million by 2034 at a CAGR of 2.75%.
• South Korea: Market size USD 112.56 million in 2025 with 5.0% share, projected to reach USD 134.11 million by 2034 at a CAGR of 1.93%.
• Thailand: Market size USD 58.80 million in 2025 with 2.6% share, projected to reach USD 67.49 million by 2034 at a CAGR of 1.53%.

Middle East & Africa

Middle East & Africa remains a nascent region in joint replacement markets but is gradually expanding. In Gulf states (UAE, Saudi Arabia), CAGR of joint replacement procedures in recent years has been ~12 % annually. Medical tourism and high spending power in the Middle East push imports and premium implant adoption. In some African markets, joint replacement penetration is extremely low (< 10 procedures per 100,000 population). Private hospitals in Middle East capture ~70 % of elective joint procedures. The region’s share of global market remains under 5 %, but growth rates in device imports exceed 15 % yearly. OEMs are setting up distribution networks across Gulf Cooperation Council (GCC) countries; tariff reductions in some nations have lowered implant cost by ~8 %.

The Middle East and Africa Joint Replacement market in 2025 is valued at USD 1048.75 million, holding 8.0% share, projected to reach USD 1292.00 million by 2034 at a CAGR of 2.33%, with strong medical tourism.

Middle East and Africa - Major Dominant Countries in the Joint Replacement Market

• Saudi Arabia: Market size USD 302.35 million in 2025 with 28.8% share, projected to reach USD 364.11 million by 2034 at a CAGR of 2.06%.
• South Africa: Market size USD 226.00 million in 2025 with 21.6% share, projected to reach USD 288.16 million by 2034 at a CAGR of 2.73%.
• UAE: Market size USD 209.57 million in 2025 with 20.0% share, projected to reach USD 260.49 million by 2034 at a CAGR of 2.47%.
• Egypt: Market size USD 172.98 million in 2025 with 16.5% share, projected to reach USD 221.23 million by 2034 at a CAGR of 2.74%.
• Nigeria: Market size USD 137.85 million in 2025 with 13.1% share, projected to reach USD 158.01 million by 2034 at a CAGR of 1.59%.

List of Top Joint Replacement Companies

• Stryker
• DePuy Synthes
• Wright Medical
• Exactech
• Zimmer Biomet
• Arthrex
• Aesculap
• Integra
• Smith & Nephew

Top Two Companies With Highest Share

• Stryker and DePuy Synthes (each commanding approximate ~15 %–18 % share in global implant market)

Investment Analysis and Opportunities

In the Joint Replacement Market Report context, investment in joint replacement technologies remains attractive. In 2024, the joint replacement devices market valuation stood around USD 23,420 million, with projections to ~USD 31,090 million by 2030. Even without referring to CAGR, this growth implies strong potential investor returns from device development, service provision, and aftermarket support. Venture capital funding in orthopaedic startups rose by 120 % between 2020 and 2023. Private equity acquisitions of implant firms numbered 25 deals in 2023, up from 12 in 2019. Key investment opportunities include robotic surgical platforms (unit installations rose ~12 % per year), smart/connected implants (sensor-enabled implant trials increased by 35 % in 2023), revision implant systems, and digital surgical planning platforms (software licensing revenue units grew by ~28 %). In emerging markets, establishing regional distribution and manufacturing capabilities can reduce import margins: for example, in India and China, local OEMs currently take ~10 %–15 % share from global giants. Hospital-capital investment in ambulatory surgical centers (ASCs) for same-day joint replacement is expanding: in U.S., ASC joint procedure share rose from ~8 % to ~20 % in five years.

New Product Development

In the Joint Replacement Market Innovation space, manufacturers are prioritizing sensor-embedded “smart” implants, augmented reality (AR)/navigation systems, modular dual mobility hip systems, personalized 3D-printed implants, and biologic coatings. In 2023, ~40 % of newly launched hip and knee implants incorporated additive manufacturing or porous coatings. Sensor-enabled implants with pressure/directional feedback are expected to be used in ~30 % of revision cases by 2028, per some forecasts in Joint Replacement Market Analysis. AR surgical glasses now assist in ~15 % of hip replacements in leading U.S. centers. Modular dual-mobility hip systems captured ~12 % share of hip implants launched in 2023, enabling increased stability in revision cases. The introduction of robotic “handheld” devices now augment ~10 % of standard manual instrumentation in medium volume hospitals. Instruments with improved wear-resistant ceramics (e.g. Oxinium, Zirconia) gained ~20 % adoption in knee femoral components in 2022–2023. In revision implants, ultra-high molecular weight polyethylene (UHMWPE) components with vitamin E infusion saw ~8 % penetration. In Asia-Pacific, a few local OEMs unveiled fully 3D-printed acetabular shells in 2023, capturing ~5 % share in that regional market. These new innovations feed directly into Joint Replacement Industry Trends and Joint Replacement Market Forecast narratives.

Five Recent Developments

• DePuy Synthes (Johnson & Johnson) gained FDA 510(k) clearance in January 2021 for its VELYS Robotic-Assisted Solution integrated with the ATTUNE Total Knee System, enabling ~10 % faster surgical workflows.
• Advertisement of mix-match implants: in 2023, ~2.5 % of hip replacement cases used “mix-match” femoral/acetabular components from different manufacturers; about 40 % of those ~2/3 involved a Stryker cup and DePuy femoral head combination.
• American Joint Replacement Registry surpassed 4 million hip and knee arthroplasty procedures in its database in March 2024, solidifying its status as largest registry by annual procedure count.
• In U.S. implant volume shifts, between 2022 and 2023 total hip and knee implant procedures increased by 4.6 % to 2.15 million procedures.
• Global joint replacement devices market valuation reached ~USD 22,500 million in 2023, with forward device forecasts of ~USD 23,420 million in 2024 and ~USD 31,090 million by 2030 based on device sales volume trends.

Report Coverage of Joint Replacement Market

This Joint Replacement Market Report or Joint Replacement Industry Report typically encompasses scope including device type (hip, knee, shoulder, extremities), procedure type (total, partial, revision), fixation (cemented, cementless, hybrid), end users (hospitals, ambulatory surgical centers, orthopedic clinics), regional coverage (North America, Europe, Asia-Pacific, MEA), and time horizon (historical 5 years to forecast 5–10 years). The coverage usually includes procedure volumes, device shipment statistics, installed base figures, implant lifetime metrics, revision rates, and pricing segmentation. The report often provides Joint Replacement Market Forecast for each segment and region, along with Joint Replacement Market Trends, Joint Replacement Market Share breakdowns by company, region, type, and application. It also includes regulatory landscape, reimbursement analysis, SWOT of major players, and Joint Replacement Market Insights regarding opportunities in emerging markets. Some reports include sensitivity analysis of pricing changes, adoption rates, and volumetric forecasts under different scenarios. Typical coverage length is ~200–300 pages, with ~10,000–15,000 data points, ~100 charts, and ~50 tables, addressing Joint Replacement Market Analysis for executives, investors, and strategic planners across the orthopaedic sector.

Joint Replacement Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 13295.63 Million in 2026
Market Size Value By	USD 15669.81 Million by 2035
Growth Rate	CAGR of 1.84% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Hip Replacement Knee Replacement Extremities Replacement By Application : Below 45 45-64 Above 65
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample